[پی آر نیوز وائر میں الفا تاؤ] الفا تاؤ نے سر اور گردن کے کینسر میں جاپانی اہم کلینکل ٹرائل کے اندراج کی تکمیل کا اعلان کیا

Alpha Tau Medical Ltd. (“Alpha Tau”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that it has been notified by HekaBio K.K., its clinical trial partner in Japan, that recruitment has been completed in its open-label multi-center pivotal study evaluating the Alpha DaRT in Japanese patients with recurrent Head & Neck cancer after radiotherapy.

مزید پڑھ یہاں.

Source: https://blog.ourcrowd.com/alpha-tau-announces-completion-of-enrollment-of-japanese-pivotal-clinical-trial-in-recurrent-head-neck-cancer/